Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.27452763 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.27452763 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.08932228 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.08932228 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.78223453 |
6 | glyoxylate metabolic process (GO:0046487) | 6.48384215 |
7 | tryptophan catabolic process (GO:0006569) | 6.30687502 |
8 | indole-containing compound catabolic process (GO:0042436) | 6.30687502 |
9 | indolalkylamine catabolic process (GO:0046218) | 6.30687502 |
10 | cysteine metabolic process (GO:0006534) | 6.28858383 |
11 | lysine catabolic process (GO:0006554) | 6.11467501 |
12 | lysine metabolic process (GO:0006553) | 6.11467501 |
13 | tryptophan metabolic process (GO:0006568) | 5.92839170 |
14 | kynurenine metabolic process (GO:0070189) | 5.83364108 |
15 | urate metabolic process (GO:0046415) | 5.76645352 |
16 | sulfur amino acid catabolic process (GO:0000098) | 5.38748731 |
17 | serine family amino acid catabolic process (GO:0009071) | 5.36407165 |
18 | bile acid biosynthetic process (GO:0006699) | 5.34033645 |
19 | * drug transmembrane transport (GO:0006855) | 5.33963101 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.27528406 |
21 | drug catabolic process (GO:0042737) | 5.16548449 |
22 | homocysteine metabolic process (GO:0050667) | 5.14026716 |
23 | aromatic amino acid family metabolic process (GO:0009072) | 4.95447379 |
24 | amino-acid betaine metabolic process (GO:0006577) | 4.93383187 |
25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.92238157 |
26 | urea metabolic process (GO:0019627) | 4.89938937 |
27 | urea cycle (GO:0000050) | 4.89938937 |
28 | epoxygenase P450 pathway (GO:0019373) | 4.76533316 |
29 | alpha-linolenic acid metabolic process (GO:0036109) | 4.75756170 |
30 | exogenous drug catabolic process (GO:0042738) | 4.73301147 |
31 | cellular ketone body metabolic process (GO:0046950) | 4.71168222 |
32 | alpha-amino acid catabolic process (GO:1901606) | 4.66000356 |
33 | serine family amino acid metabolic process (GO:0009069) | 4.65078250 |
34 | short-chain fatty acid metabolic process (GO:0046459) | 4.58429796 |
35 | * drug transport (GO:0015893) | 4.57580160 |
36 | nitrogen cycle metabolic process (GO:0071941) | 4.57155444 |
37 | bile acid metabolic process (GO:0008206) | 4.54596952 |
38 | cellular modified amino acid catabolic process (GO:0042219) | 4.54305046 |
39 | cellular glucuronidation (GO:0052695) | 4.50019754 |
40 | glutamate metabolic process (GO:0006536) | 4.46917633 |
41 | indolalkylamine metabolic process (GO:0006586) | 4.44490626 |
42 | cellular amino acid catabolic process (GO:0009063) | 4.43545014 |
43 | tyrosine metabolic process (GO:0006570) | 4.36827560 |
44 | benzene-containing compound metabolic process (GO:0042537) | 4.36587609 |
45 | amine catabolic process (GO:0009310) | 4.30187839 |
46 | cellular biogenic amine catabolic process (GO:0042402) | 4.30187839 |
47 | protein carboxylation (GO:0018214) | 4.29903696 |
48 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.29903696 |
49 | high-density lipoprotein particle remodeling (GO:0034375) | 4.29898165 |
50 | aspartate family amino acid catabolic process (GO:0009068) | 4.29889581 |
51 | serine family amino acid biosynthetic process (GO:0009070) | 4.29478335 |
52 | negative regulation of fibrinolysis (GO:0051918) | 4.27232223 |
53 | angiotensin maturation (GO:0002003) | 4.24402588 |
54 | uronic acid metabolic process (GO:0006063) | 4.22763277 |
55 | glucuronate metabolic process (GO:0019585) | 4.22763277 |
56 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.22267871 |
57 | complement activation, alternative pathway (GO:0006957) | 4.10759605 |
58 | aldehyde catabolic process (GO:0046185) | 4.09570365 |
59 | response to mercury ion (GO:0046689) | 4.08119554 |
60 | ketone body metabolic process (GO:1902224) | 4.07773977 |
61 | regulation of fibrinolysis (GO:0051917) | 4.07304296 |
62 | acetyl-CoA metabolic process (GO:0006084) | 4.04397579 |
63 | negative regulation of sterol transport (GO:0032372) | 4.03889195 |
64 | negative regulation of cholesterol transport (GO:0032375) | 4.03889195 |
65 | 2-oxoglutarate metabolic process (GO:0006103) | 4.03698922 |
66 | regulation of protein activation cascade (GO:2000257) | 4.03174822 |
67 | ethanol oxidation (GO:0006069) | 4.01911237 |
68 | glycine metabolic process (GO:0006544) | 4.01177563 |
69 | coenzyme catabolic process (GO:0009109) | 3.99578867 |
70 | carboxylic acid catabolic process (GO:0046395) | 3.95458555 |
71 | organic acid catabolic process (GO:0016054) | 3.95458555 |
72 | flavonoid metabolic process (GO:0009812) | 3.94950739 |
73 | fatty acid beta-oxidation (GO:0006635) | 3.94685083 |
74 | regulation of triglyceride catabolic process (GO:0010896) | 3.93051863 |
75 | fatty acid oxidation (GO:0019395) | 3.89480777 |
76 | carnitine metabolic process (GO:0009437) | 3.87943977 |
77 | bile acid and bile salt transport (GO:0015721) | 3.86896896 |
78 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.84986741 |
79 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.84709592 |
80 | regulation of cholesterol esterification (GO:0010872) | 3.83920347 |
81 | valine metabolic process (GO:0006573) | 3.83032704 |
82 | lipid oxidation (GO:0034440) | 3.81903296 |
83 | acylglycerol homeostasis (GO:0055090) | 3.80295402 |
84 | triglyceride homeostasis (GO:0070328) | 3.80295402 |
85 | regulation of complement activation (GO:0030449) | 3.77581750 |
86 | reverse cholesterol transport (GO:0043691) | 3.74033187 |
87 | regulation of cholesterol homeostasis (GO:2000188) | 3.72838644 |
88 | drug metabolic process (GO:0017144) | 3.72815107 |
89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72704906 |
90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72704906 |
91 | monocarboxylic acid catabolic process (GO:0072329) | 3.71945482 |
92 | plasma lipoprotein particle remodeling (GO:0034369) | 3.70143706 |
93 | protein-lipid complex remodeling (GO:0034368) | 3.70143706 |
94 | macromolecular complex remodeling (GO:0034367) | 3.70143706 |
95 | phosphate ion transport (GO:0006817) | 3.69072012 |
96 | arginine metabolic process (GO:0006525) | 3.68633003 |
97 | response to nitrosative stress (GO:0051409) | 3.65418548 |
98 | fatty acid catabolic process (GO:0009062) | 3.64943645 |
99 | branched-chain amino acid metabolic process (GO:0009081) | 3.62063476 |
100 | intestinal absorption (GO:0050892) | 3.60590817 |
101 | phospholipid efflux (GO:0033700) | 3.53858686 |
102 | phosphate ion transmembrane transport (GO:0035435) | 3.51441736 |
103 | regulation of bile acid biosynthetic process (GO:0070857) | 3.48593564 |
104 | branched-chain amino acid catabolic process (GO:0009083) | 3.45755214 |
105 | imidazole-containing compound metabolic process (GO:0052803) | 3.44725119 |
106 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.43233998 |
107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.43233998 |
108 | alkaloid metabolic process (GO:0009820) | 3.42096451 |
109 | plasma lipoprotein particle assembly (GO:0034377) | 3.23110002 |
110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.20466907 |
111 | diacylglycerol metabolic process (GO:0046339) | 3.15638750 |
112 | omega-hydroxylase P450 pathway (GO:0097267) | 3.10072795 |
113 | cholesterol efflux (GO:0033344) | 3.06116972 |
114 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.05961219 |
115 | hormone catabolic process (GO:0042447) | 3.03249080 |
116 | positive regulation of lipid catabolic process (GO:0050996) | 3.01698353 |
117 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.95672241 |
118 | acute-phase response (GO:0006953) | 2.93164055 |
119 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.90051796 |
120 | peptide catabolic process (GO:0043171) | 2.89264617 |
121 | plasma lipoprotein particle organization (GO:0071827) | 2.87709358 |
122 | regulation of guanylate cyclase activity (GO:0031282) | 2.86784598 |
123 | protein-lipid complex assembly (GO:0065005) | 2.85662208 |
124 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84389456 |
125 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80692918 |
126 | glycosphingolipid catabolic process (GO:0046479) | 2.79138965 |
127 | complement activation, classical pathway (GO:0006958) | 2.73854444 |
128 | protein-lipid complex subunit organization (GO:0071825) | 2.69428783 |
129 | complement activation (GO:0006956) | 2.69265488 |
130 | lipoprotein metabolic process (GO:0042157) | 2.67308965 |
131 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.65293755 |
132 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.65293755 |
133 | endocrine process (GO:0050886) | 2.65293755 |
134 | arginine catabolic process (GO:0006527) | 2.64991088 |
135 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64952043 |
136 | ethanol metabolic process (GO:0006067) | 2.64585028 |
137 | virion attachment to host cell (GO:0019062) | 2.64327157 |
138 | adhesion of symbiont to host cell (GO:0044650) | 2.64327157 |
139 | phenylpropanoid metabolic process (GO:0009698) | 2.60516958 |
140 | fructose metabolic process (GO:0006000) | 2.59935214 |
141 | glycolipid catabolic process (GO:0019377) | 2.59246832 |
142 | protein activation cascade (GO:0072376) | 2.58163685 |
143 | low-density lipoprotein particle remodeling (GO:0034374) | 2.57799259 |
144 | regulation of triglyceride metabolic process (GO:0090207) | 2.56927078 |
145 | glutathione biosynthetic process (GO:0006750) | 2.56561532 |
146 | plasma lipoprotein particle clearance (GO:0034381) | 2.54276509 |
147 | adhesion of symbiont to host (GO:0044406) | 2.53061569 |
148 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.52217219 |
149 | fibrinolysis (GO:0042730) | 2.51526260 |
150 | mannose metabolic process (GO:0006013) | 2.50972341 |
151 | intestinal cholesterol absorption (GO:0030299) | 2.47602016 |
152 | oligosaccharide catabolic process (GO:0009313) | 2.44411569 |
153 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.43451568 |
154 | amyloid precursor protein catabolic process (GO:0042987) | 2.42496911 |
155 | cholesterol homeostasis (GO:0042632) | 2.42384641 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.02352686 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.92425362 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.12558186 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.12430055 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.07010478 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.65506926 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.43173213 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.65496975 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.64498891 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.16713114 |
11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.47346969 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.40891111 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31431585 |
14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.11586983 |
15 | * BCL6_27268052_Chip-Seq_Bcells_Human | 2.00237104 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1257427 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.96654156 |
18 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.83496526 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76421897 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67947025 |
21 | * P68_20966046_ChIP-Seq_HELA_Human | 1.67450809 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64441101 |
23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60913185 |
24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58721991 |
25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57474315 |
26 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.56679469 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56016293 |
28 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55527521 |
29 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.54647082 |
30 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.52316297 |
31 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.51824568 |
32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49945154 |
33 | SA1_27219007_Chip-Seq_Bcells_Human | 1.49356574 |
34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48323782 |
35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43514667 |
36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39491988 |
37 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.38444515 |
38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38391779 |
39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34222226 |
40 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33156139 |
41 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32332323 |
42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31397917 |
43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.29698196 |
44 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.29508034 |
45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26788495 |
46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26621858 |
47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26027047 |
48 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25161853 |
49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25027973 |
50 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.24355928 |
51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23727214 |
52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23266010 |
53 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22361328 |
54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22078589 |
55 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.21555299 |
56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20400622 |
57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18363915 |
58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18129584 |
59 | P300_27268052_Chip-Seq_Bcells_Human | 1.17445459 |
60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16082426 |
61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15614831 |
62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14995323 |
63 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14556855 |
64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14422241 |
65 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14363266 |
66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13215373 |
67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12691522 |
68 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.11151409 |
69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11083858 |
70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10759572 |
71 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10174366 |
72 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10114376 |
73 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.08857241 |
74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08655851 |
75 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08225931 |
76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07929904 |
77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07686127 |
78 | ERA_21632823_ChIP-Seq_H3396_Human | 1.06096160 |
79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05799586 |
80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04068074 |
81 | * RAC3_21632823_ChIP-Seq_H3396_Human | 1.04002695 |
82 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02683323 |
83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02578501 |
84 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.01002251 |
85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99565565 |
86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99360148 |
87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99127693 |
88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98943980 |
89 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.98483883 |
90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98177852 |
91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97933567 |
92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97787075 |
93 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97240570 |
94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97204567 |
95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96984670 |
96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90783924 |
97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87243658 |
98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85161962 |
99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80955171 |
100 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80438378 |
101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80389070 |
102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77078464 |
103 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.77070754 |
104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76803354 |
105 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74783637 |
106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.74411156 |
107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74322486 |
108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73459828 |
109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73431928 |
110 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72833439 |
111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71910767 |
112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71773937 |
113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69358921 |
114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68349287 |
115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67299828 |
116 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67076304 |
117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65236513 |
118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65236513 |
119 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64934920 |
120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63816441 |
121 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.63477014 |
122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63445938 |
123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62518016 |
124 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.62467880 |
125 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.61939179 |
126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.61737196 |
127 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.60732208 |
128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.60374903 |
129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.57115169 |
130 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57080892 |
131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56849526 |
132 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.56783984 |
133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56134534 |
134 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.56020988 |
135 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55711379 |
136 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55458618 |
137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55414053 |
138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55279305 |
139 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.55005806 |
140 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53431074 |
141 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.53171105 |
142 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51961423 |
143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.50907697 |
144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50776237 |
145 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.49995106 |
146 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48436868 |
147 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.47838317 |
148 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.46902959 |
149 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46439385 |
150 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.46347194 |
151 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.46321755 |
152 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45842151 |
153 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.45538380 |
154 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.45109350 |
155 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.44707514 |
156 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.44474431 |
157 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44269114 |
158 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43635647 |
159 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42802440 |
160 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42790225 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 8.28628650 |
2 | MP0002139_abnormal_hepatobiliary_system | 7.82621345 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.54759938 |
4 | MP0005365_abnormal_bile_salt | 5.43899658 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02910501 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.68432104 |
7 | MP0003252_abnormal_bile_duct | 3.67283981 |
8 | MP0005332_abnormal_amino_acid | 3.65052038 |
9 | MP0003195_calcinosis | 3.28118091 |
10 | MP0004019_abnormal_vitamin_homeostasis | 3.20283782 |
11 | MP0010329_abnormal_lipoprotein_level | 2.98363861 |
12 | MP0002138_abnormal_hepatobiliary_system | 2.63775404 |
13 | MP0009840_abnormal_foam_cell | 2.54948988 |
14 | MP0001666_abnormal_nutrient_absorption | 2.50143519 |
15 | MP0005083_abnormal_biliary_tract | 2.31932674 |
16 | MP0003172_abnormal_lysosome_physiology | 2.26443329 |
17 | MP0009643_abnormal_urine_homeostasis | 2.25778431 |
18 | MP0004043_abnormal_pH_regulation | 2.17769378 |
19 | MP0003191_abnormal_cellular_cholesterol | 2.17181123 |
20 | MP0010155_abnormal_intestine_physiology | 1.92692387 |
21 | MP0003183_abnormal_peptide_metabolism | 1.89395077 |
22 | MP0002118_abnormal_lipid_homeostasis | 1.87619708 |
23 | MP0005319_abnormal_enzyme/_coenzyme | 1.86122159 |
24 | MP0000609_abnormal_liver_physiology | 1.84579981 |
25 | MP0009785_altered_susceptibility_to | 1.80033410 |
26 | MP0005636_abnormal_mineral_homeostasis | 1.76046231 |
27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.70070940 |
28 | MP0005025_abnormal_response_to | 1.65736883 |
29 | MP0001764_abnormal_homeostasis | 1.64207782 |
30 | MP0003186_abnormal_redox_activity | 1.63884937 |
31 | MP0002148_abnormal_hypersensitivity_rea | 1.60324209 |
32 | MP0003303_peritoneal_inflammation | 1.55286063 |
33 | MP0002419_abnormal_innate_immunity | 1.55187171 |
34 | MP0005451_abnormal_body_composition | 1.54357573 |
35 | MP0001873_stomach_inflammation | 1.51715242 |
36 | MP0001835_abnormal_antigen_presentation | 1.49043361 |
37 | MP0003868_abnormal_feces_composition | 1.48741237 |
38 | MP0005387_immune_system_phenotype | 1.48705186 |
39 | MP0001790_abnormal_immune_system | 1.48705186 |
40 | MP0001756_abnormal_urination | 1.48323843 |
41 | MP0000685_abnormal_immune_system | 1.38396151 |
42 | MP0003866_abnormal_defecation | 1.35855091 |
43 | MP0001765_abnormal_ion_homeostasis | 1.35003645 |
44 | MP0003879_abnormal_hair_cell | 1.34716661 |
45 | MP0002136_abnormal_kidney_physiology | 1.31330871 |
46 | MP0000678_abnormal_parathyroid_gland | 1.30846103 |
47 | MP0001533_abnormal_skeleton_physiology | 1.27147625 |
48 | MP0005000_abnormal_immune_tolerance | 1.23448618 |
49 | MP0002132_abnormal_respiratory_system | 1.21052468 |
50 | MP0005671_abnormal_response_to | 1.21013949 |
51 | MP0001800_abnormal_humoral_immune | 1.18319444 |
52 | MP0002723_abnormal_immune_serum | 1.14750904 |
53 | MP0002876_abnormal_thyroid_physiology | 1.08810413 |
54 | MP0004947_skin_inflammation | 1.07412780 |
55 | MP0002452_abnormal_antigen_presenting | 1.06640788 |
56 | MP0000598_abnormal_liver_morphology | 1.06204472 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.06157877 |
58 | MP0009764_decreased_sensitivity_to | 1.05889759 |
59 | MP0006036_abnormal_mitochondrial_physio | 1.04894230 |
60 | MP0005084_abnormal_gallbladder_morpholo | 1.03971173 |
61 | MP0003705_abnormal_hypodermis_morpholog | 1.03160726 |
62 | MP0005310_abnormal_salivary_gland | 1.02442461 |
63 | MP0004858_abnormal_nervous_system | 1.02249909 |
64 | MP0005410_abnormal_fertilization | 0.95576699 |
65 | MP0009642_abnormal_blood_homeostasis | 0.91927951 |
66 | MP0009697_abnormal_copulation | 0.91793868 |
67 | MP0005670_abnormal_white_adipose | 0.91651329 |
68 | MP0003656_abnormal_erythrocyte_physiolo | 0.91596770 |
69 | MP0001819_abnormal_immune_cell | 0.91234338 |
70 | MP0002420_abnormal_adaptive_immunity | 0.89658345 |
71 | MP0008469_abnormal_protein_level | 0.89320310 |
72 | MP0005647_abnormal_sex_gland | 0.88734430 |
73 | MP0002998_abnormal_bone_remodeling | 0.87803810 |
74 | MP0005058_abnormal_lysosome_morphology | 0.86042918 |
75 | MP0001664_abnormal_digestion | 0.85248213 |
76 | MP0004510_myositis | 0.84338738 |
77 | MP0003011_delayed_dark_adaptation | 0.83849332 |
78 | MP0005381_digestive/alimentary_phenotyp | 0.83821492 |
79 | MP0000604_amyloidosis | 0.82315945 |
80 | MP0005408_hypopigmentation | 0.82016791 |
81 | MP0005535_abnormal_body_temperature | 0.80133942 |
82 | MP0009763_increased_sensitivity_to | 0.79354378 |
83 | MP0008260_abnormal_autophagy | 0.79049630 |
84 | MP0005220_abnormal_exocrine_pancreas | 0.77939580 |
85 | MP0000538_abnormal_urinary_bladder | 0.73483924 |
86 | MP0002078_abnormal_glucose_homeostasis | 0.71571660 |
87 | MP0002254_reproductive_system_inflammat | 0.71387445 |
88 | MP0009765_abnormal_xenobiotic_induced | 0.71078195 |
89 | MP0002928_abnormal_bile_duct | 0.71002485 |
90 | MP0005376_homeostasis/metabolism_phenot | 0.70564672 |
91 | MP0000249_abnormal_blood_vessel | 0.69603519 |
92 | MP0002933_joint_inflammation | 0.68940210 |
93 | MP0000858_altered_metastatic_potential | 0.67094364 |
94 | MP0000015_abnormal_ear_pigmentation | 0.66160523 |
95 | MP0005257_abnormal_intraocular_pressure | 0.65412511 |
96 | MP0001661_extended_life_span | 0.65050994 |
97 | MP0000343_altered_response_to | 0.63886158 |
98 | MP0004264_abnormal_extraembryonic_tissu | 0.63523565 |
99 | MP0003638_abnormal_response/metabolism_ | 0.63281393 |
100 | MP0000230_abnormal_systemic_arterial | 0.59940166 |
101 | MP0003878_abnormal_ear_physiology | 0.59654911 |
102 | MP0005377_hearing/vestibular/ear_phenot | 0.59654911 |
103 | MP0009053_abnormal_anal_canal | 0.59488305 |
104 | MP0002971_abnormal_brown_adipose | 0.58091480 |
105 | MP0005266_abnormal_metabolism | 0.57801163 |
106 | MP0003300_gastrointestinal_ulcer | 0.56249673 |
107 | MP0005666_abnormal_adipose_tissue | 0.55428214 |
108 | MP0002168_other_aberrant_phenotype | 0.54916330 |
109 | MP0005334_abnormal_fat_pad | 0.54643355 |
110 | MP0005395_other_phenotype | 0.54207554 |
111 | MP0003329_amyloid_beta_deposits | 0.53375561 |
112 | MP0002135_abnormal_kidney_morphology | 0.53006503 |
113 | MP0002796_impaired_skin_barrier | 0.52718867 |
114 | MP0006035_abnormal_mitochondrial_morpho | 0.52622003 |
115 | MP0010234_abnormal_vibrissa_follicle | 0.52153073 |
116 | MP0010368_abnormal_lymphatic_system | 0.51129810 |
117 | MP0003724_increased_susceptibility_to | 0.49711298 |
118 | MP0004147_increased_porphyrin_level | 0.48661833 |
119 | MP0008961_abnormal_basal_metabolism | 0.46400808 |
120 | MP0003953_abnormal_hormone_level | 0.45038030 |
121 | MP0004782_abnormal_surfactant_physiolog | 0.43393143 |
122 | MP0004130_abnormal_muscle_cell | 0.41772503 |
123 | MP0003690_abnormal_glial_cell | 0.41594781 |
124 | MP0008872_abnormal_physiological_respon | 0.41455245 |
125 | MP0005166_decreased_susceptibility_to | 0.41260909 |
126 | MP0003075_altered_response_to | 0.40970861 |
127 | MP0008873_increased_physiological_sensi | 0.38162139 |
128 | MP0008874_decreased_physiological_sensi | 0.36968057 |
129 | MP0001845_abnormal_inflammatory_respons | 0.36848536 |
130 | MP0005448_abnormal_energy_balance | 0.36290458 |
131 | MP0005464_abnormal_platelet_physiology | 0.36170724 |
132 | MP0001958_emphysema | 0.33977036 |
133 | MP0003959_abnormal_lean_body | 0.33190086 |
134 | MP0003718_maternal_effect | 0.32205602 |
135 | MP0005167_abnormal_blood-brain_barrier | 0.31026562 |
136 | MP0006082_CNS_inflammation | 0.30330666 |
137 | MP0009115_abnormal_fat_cell | 0.29611851 |
138 | MP0009672_abnormal_birth_weight | 0.28857855 |
139 | MP0003436_decreased_susceptibility_to | 0.28494276 |
140 | MP0001663_abnormal_digestive_system | 0.27933756 |
141 | MP0002822_catalepsy | 0.27138285 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.33820995 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.70412491 |
3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.30044239 |
4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.23117073 |
5 | Deep venous thrombosis (HP:0002625) | 5.20416292 |
6 | Xanthomatosis (HP:0000991) | 5.08564062 |
7 | Hyperglycinuria (HP:0003108) | 5.04597312 |
8 | Gout (HP:0001997) | 4.86280523 |
9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.59900671 |
10 | Abnormality of glycine metabolism (HP:0010895) | 4.59900671 |
11 | Ketosis (HP:0001946) | 4.50727939 |
12 | Hypobetalipoproteinemia (HP:0003563) | 4.49999367 |
13 | Hyperammonemia (HP:0001987) | 4.41249312 |
14 | Prolonged partial thromboplastin time (HP:0003645) | 4.39076650 |
15 | Hyperglycinemia (HP:0002154) | 4.35620473 |
16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.25451681 |
17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.04202110 |
18 | Abnormality of purine metabolism (HP:0004352) | 4.01631803 |
19 | Glomerulonephritis (HP:0000099) | 3.94504202 |
20 | Hyperlipoproteinemia (HP:0010980) | 3.89747566 |
21 | Ketoacidosis (HP:0001993) | 3.79857226 |
22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.79402576 |
23 | Proximal tubulopathy (HP:0000114) | 3.74532017 |
24 | Abnormality of nucleobase metabolism (HP:0010932) | 3.73836804 |
25 | Complement deficiency (HP:0004431) | 3.63884994 |
26 | Joint hemorrhage (HP:0005261) | 3.56481949 |
27 | Hyperuricemia (HP:0002149) | 3.54678619 |
28 | Increased purine levels (HP:0004368) | 3.54678619 |
29 | Alkalosis (HP:0001948) | 3.53633646 |
30 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.53106507 |
31 | Hemorrhage of the eye (HP:0011885) | 3.47444554 |
32 | Generalized aminoaciduria (HP:0002909) | 3.44897506 |
33 | Delayed CNS myelination (HP:0002188) | 3.43697273 |
34 | Hypoglycemic coma (HP:0001325) | 3.43125882 |
35 | Fat malabsorption (HP:0002630) | 3.39144618 |
36 | Hypolipoproteinemia (HP:0010981) | 3.36946370 |
37 | Hypokalemic alkalosis (HP:0001949) | 3.35075712 |
38 | Hyperactive renin-angiotensin system (HP:0000841) | 3.33020988 |
39 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.31276654 |
40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.31276654 |
41 | Abnormality of glycolipid metabolism (HP:0010969) | 3.31276654 |
42 | Abnormality of methionine metabolism (HP:0010901) | 3.22361415 |
43 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.18246806 |
44 | Epidermoid cyst (HP:0200040) | 3.17371220 |
45 | Metabolic alkalosis (HP:0200114) | 3.15187585 |
46 | Vacuolated lymphocytes (HP:0001922) | 3.14504823 |
47 | Metabolic acidosis (HP:0001942) | 3.13468732 |
48 | Abnormality of the common coagulation pathway (HP:0010990) | 3.12738256 |
49 | Increased circulating renin level (HP:0000848) | 3.11412921 |
50 | Orchitis (HP:0100796) | 3.09162024 |
51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.06744833 |
52 | Dicarboxylic aciduria (HP:0003215) | 3.06744833 |
53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.04917610 |
54 | Eczematoid dermatitis (HP:0000976) | 3.04789782 |
55 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.02974644 |
56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.02974644 |
57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.02974644 |
58 | Vascular calcification (HP:0004934) | 3.02176775 |
59 | Increased cerebral lipofuscin (HP:0011813) | 2.98767788 |
60 | Myositis (HP:0100614) | 2.97837560 |
61 | Abnormality of macrophages (HP:0004311) | 2.95588532 |
62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.94852541 |
63 | Hypoalphalipoproteinemia (HP:0003233) | 2.94047176 |
64 | Abnormality of urine glucose concentration (HP:0011016) | 2.92248596 |
65 | Glycosuria (HP:0003076) | 2.92248596 |
66 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90855246 |
67 | Abnormality of serum amino acid levels (HP:0003112) | 2.90611729 |
68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89664386 |
69 | Dysostosis multiplex (HP:0000943) | 2.88805184 |
70 | Recurrent abscess formation (HP:0002722) | 2.87965305 |
71 | Nephritis (HP:0000123) | 2.85979362 |
72 | Lethargy (HP:0001254) | 2.85481498 |
73 | Abnormality of chloride homeostasis (HP:0011422) | 2.85247027 |
74 | Abnormal urine output (HP:0012590) | 2.85028962 |
75 | Abnormality of proline metabolism (HP:0010907) | 2.83107358 |
76 | Hydroxyprolinuria (HP:0003080) | 2.83107358 |
77 | Hyperbilirubinemia (HP:0002904) | 2.81593306 |
78 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.81209533 |
79 | Mucopolysacchariduria (HP:0008155) | 2.81209533 |
80 | Malnutrition (HP:0004395) | 2.78796557 |
81 | Hypomagnesemia (HP:0002917) | 2.76189472 |
82 | Polyuria (HP:0000103) | 2.75637790 |
83 | Hepatocellular carcinoma (HP:0001402) | 2.72665507 |
84 | Purpura (HP:0000979) | 2.72269471 |
85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.67420668 |
86 | Cardiovascular calcification (HP:0011915) | 2.67146801 |
87 | Abnormality of renal excretion (HP:0011036) | 2.65330025 |
88 | Abnormality of the intrinsic pathway (HP:0010989) | 2.64988831 |
89 | Amyloidosis (HP:0011034) | 2.60424157 |
90 | Abnormality of complement system (HP:0005339) | 2.60274726 |
91 | Vomiting (HP:0002013) | 2.58485862 |
92 | Retrobulbar optic neuritis (HP:0100654) | 2.58252024 |
93 | Optic neuritis (HP:0100653) | 2.58252024 |
94 | Recurrent bacterial skin infections (HP:0005406) | 2.57134045 |
95 | Steatorrhea (HP:0002570) | 2.53636916 |
96 | Hypercholesterolemia (HP:0003124) | 2.53165889 |
97 | Rickets (HP:0002748) | 2.52977744 |
98 | Irritability (HP:0000737) | 2.51696472 |
99 | Enlarged kidneys (HP:0000105) | 2.48914870 |
100 | Widely patent fontanelles and sutures (HP:0004492) | 2.47511106 |
101 | Increased serum ferritin (HP:0003281) | 2.47324340 |
102 | J-shaped sella turcica (HP:0002680) | 2.42757740 |
103 | Neonatal onset (HP:0003623) | 2.42441996 |
104 | Nephrolithiasis (HP:0000787) | 2.38391315 |
105 | Prolonged neonatal jaundice (HP:0006579) | 2.35747511 |
106 | Spastic diplegia (HP:0001264) | 2.34786377 |
107 | Abnormality of magnesium homeostasis (HP:0004921) | 2.34726953 |
108 | Gingivitis (HP:0000230) | 2.33628044 |
109 | Cerebral edema (HP:0002181) | 2.33120701 |
110 | Pustule (HP:0200039) | 2.32743211 |
111 | Congenital sensorineural hearing impairment (HP:0008527) | 2.30127961 |
112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.29402746 |
113 | Loss of speech (HP:0002371) | 2.29125327 |
114 | Hyperphosphaturia (HP:0003109) | 2.28820384 |
115 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26207228 |
116 | Sensorimotor neuropathy (HP:0007141) | 2.26057574 |
117 | Renal tubular acidosis (HP:0001947) | 2.24174580 |
118 | Late onset (HP:0003584) | 2.22869003 |
119 | Ileus (HP:0002595) | 2.20773194 |
120 | Abnormality of iron homeostasis (HP:0011031) | 2.20137541 |
121 | Chronic diarrhea (HP:0002028) | 2.19506975 |
122 | Systemic lupus erythematosus (HP:0002725) | 2.19245271 |
123 | Obstructive lung disease (HP:0006536) | 2.17929712 |
124 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17929712 |
125 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17013595 |
126 | Thin bony cortex (HP:0002753) | 2.17006148 |
127 | Gastrointestinal infarctions (HP:0005244) | 2.15579338 |
128 | Pancreatitis (HP:0001733) | 2.14988755 |
129 | Cerebral palsy (HP:0100021) | 2.11755406 |
130 | Petechiae (HP:0000967) | 2.10052117 |
131 | Confusion (HP:0001289) | 2.09374508 |
132 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.09258274 |
133 | Abnormal drinking behavior (HP:0030082) | 2.09224218 |
134 | Polydipsia (HP:0001959) | 2.09224218 |
135 | Myocardial infarction (HP:0001658) | 2.09088496 |
136 | Abnormality of renin-angiotensin system (HP:0000847) | 2.07451601 |
137 | Renal salt wasting (HP:0000127) | 2.04841659 |
138 | Abnormal tarsal ossification (HP:0008369) | 2.03562596 |
139 | Abdominal distention (HP:0003270) | 2.03339640 |
140 | Nausea (HP:0002018) | 2.01905913 |
141 | Hyperaldosteronism (HP:0000859) | 2.01373652 |
142 | Hypophosphatemia (HP:0002148) | 2.01339817 |
143 | Gingival bleeding (HP:0000225) | 2.01239415 |
144 | Abnormal urine phosphate concentration (HP:0012599) | 1.99747349 |
145 | Hypoglycemic seizures (HP:0002173) | 1.95599187 |
146 | Hypophosphatemic rickets (HP:0004912) | 1.95511805 |
147 | Esophageal varix (HP:0002040) | 1.95497140 |
148 | Spontaneous abortion (HP:0005268) | 1.95206761 |
149 | Axonal loss (HP:0003447) | 1.94986895 |
150 | Vasculitis (HP:0002633) | 1.94135954 |
151 | Pulmonary infiltrates (HP:0002113) | 1.93474451 |
152 | Protuberant abdomen (HP:0001538) | 1.93017166 |
153 | Focal segmental glomerulosclerosis (HP:0000097) | 1.92122366 |
154 | Retinal atrophy (HP:0001105) | 1.90761057 |
155 | Pigmentary retinal degeneration (HP:0001146) | 1.90283073 |
156 | Pulmonary embolism (HP:0002204) | 1.87050331 |
157 | Hemoptysis (HP:0002105) | 1.83178567 |
158 | Decreased circulating renin level (HP:0003351) | 1.81669910 |
159 | Stomatitis (HP:0010280) | 1.79627850 |
160 | Recurrent skin infections (HP:0001581) | 1.79121936 |
161 | Acne (HP:0001061) | 1.78664659 |
162 | Progressive neurologic deterioration (HP:0002344) | 1.78588613 |
163 | Facial shape deformation (HP:0011334) | 1.77811526 |
164 | Potter facies (HP:0002009) | 1.77811526 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.64859200 |
2 | WNK4 | 5.02387655 |
3 | WNK3 | 4.65133949 |
4 | OXSR1 | 3.99105380 |
5 | FGFR4 | 3.63232719 |
6 | ERN1 | 3.37957246 |
7 | EPHA2 | 2.71854933 |
8 | SIK1 | 2.66750984 |
9 | MST1R | 2.46149650 |
10 | ACVR1B | 2.25477510 |
11 | LMTK2 | 2.19520686 |
12 | STK38L | 2.04591311 |
13 | RIPK4 | 1.99826265 |
14 | IRAK4 | 1.94604080 |
15 | INSRR | 1.94503538 |
16 | STK39 | 1.92322128 |
17 | MAP3K3 | 1.86873174 |
18 | TAOK3 | 1.82919952 |
19 | FRK | 1.82915024 |
20 | ERBB4 | 1.80896143 |
21 | MAPK11 | 1.47452759 |
22 | TAOK1 | 1.47378949 |
23 | TXK | 1.45095031 |
24 | TNK2 | 1.43950241 |
25 | PKN2 | 1.39430138 |
26 | PDK3 | 1.37557579 |
27 | PDK4 | 1.37557579 |
28 | DDR2 | 1.36108618 |
29 | PTK6 | 1.35546789 |
30 | TESK1 | 1.34648097 |
31 | GRK6 | 1.32528123 |
32 | TESK2 | 1.31707454 |
33 | MAP2K4 | 1.31658326 |
34 | TRIB3 | 1.29573400 |
35 | BLK | 1.26501403 |
36 | SGK494 | 1.23705288 |
37 | SGK223 | 1.23705288 |
38 | FLT3 | 1.23618482 |
39 | ABL2 | 1.23009035 |
40 | ZAP70 | 1.22437043 |
41 | PIK3CG | 1.22103223 |
42 | PINK1 | 1.20316267 |
43 | MATK | 1.18563503 |
44 | IKBKB | 1.18401165 |
45 | SIK2 | 1.17141816 |
46 | TYK2 | 1.13184600 |
47 | ADRBK2 | 1.11926402 |
48 | MAP3K7 | 1.11042206 |
49 | NEK1 | 1.09153312 |
50 | MAP2K3 | 1.08917892 |
51 | EPHB1 | 1.08124608 |
52 | MAP3K2 | 1.01944184 |
53 | TIE1 | 0.97789987 |
54 | PRKD2 | 0.97074016 |
55 | LATS1 | 0.95763983 |
56 | SGK3 | 0.95420893 |
57 | PRKAA2 | 0.94950051 |
58 | SIK3 | 0.93264006 |
59 | CDC42BPA | 0.93028292 |
60 | PDK2 | 0.90348068 |
61 | MAP3K14 | 0.90003712 |
62 | PIM2 | 0.89586752 |
63 | MET | 0.88322570 |
64 | SMG1 | 0.88142808 |
65 | JAK2 | 0.87265838 |
66 | DYRK1B | 0.87137082 |
67 | GSK3A | 0.87095249 |
68 | NEK9 | 0.85859040 |
69 | PIK3CA | 0.84555929 |
70 | SGK2 | 0.83837021 |
71 | KDR | 0.83770982 |
72 | ICK | 0.83102695 |
73 | MAP3K11 | 0.82272029 |
74 | MAP2K2 | 0.81374652 |
75 | MAPK15 | 0.80676655 |
76 | MAPKAPK3 | 0.79908140 |
77 | TGFBR2 | 0.75704538 |
78 | RPS6KA2 | 0.74930914 |
79 | PTK2 | 0.74626306 |
80 | IRAK3 | 0.74195388 |
81 | JAK3 | 0.73395828 |
82 | TBK1 | 0.72400801 |
83 | GRK7 | 0.71930883 |
84 | FES | 0.71602488 |
85 | PRPF4B | 0.70336443 |
86 | RIPK1 | 0.69724418 |
87 | TLK1 | 0.68592726 |
88 | STK38 | 0.68550429 |
89 | PRKAA1 | 0.66344490 |
90 | PRKCZ | 0.65855913 |
91 | MAP2K6 | 0.63535028 |
92 | SYK | 0.62704393 |
93 | ERBB2 | 0.61963805 |
94 | PRKCI | 0.61905741 |
95 | LRRK2 | 0.61612702 |
96 | CHUK | 0.61364002 |
97 | DAPK2 | 0.60537627 |
98 | MAPK4 | 0.59963172 |
99 | BTK | 0.57117122 |
100 | LYN | 0.56921399 |
101 | ITK | 0.55665153 |
102 | LCK | 0.55317940 |
103 | HIPK2 | 0.55261307 |
104 | MARK2 | 0.54819656 |
105 | PDPK1 | 0.54772512 |
106 | PRKACG | 0.54762864 |
107 | FGR | 0.53003859 |
108 | MAP3K10 | 0.52061961 |
109 | JAK1 | 0.48871995 |
110 | CSK | 0.46061186 |
111 | RPS6KC1 | 0.45234061 |
112 | RPS6KL1 | 0.45234061 |
113 | IRAK2 | 0.44466576 |
114 | WNK1 | 0.44355222 |
115 | RPS6KA6 | 0.43956723 |
116 | BMX | 0.42944420 |
117 | MAPK12 | 0.42728284 |
118 | HCK | 0.42387250 |
119 | CAMK2G | 0.40861262 |
120 | MUSK | 0.40498779 |
121 | MYLK | 0.39244828 |
122 | FGFR2 | 0.39153178 |
123 | CDK6 | 0.37662875 |
124 | MAP2K1 | 0.36337914 |
125 | EPHA3 | 0.34013635 |
126 | PDK1 | 0.33303979 |
127 | IKBKE | 0.32570909 |
128 | FER | 0.32037914 |
129 | PRKG2 | 0.28110533 |
130 | PRKCQ | 0.28034698 |
131 | TAOK2 | 0.26150727 |
132 | IGF1R | 0.25780341 |
133 | IRAK1 | 0.25357946 |
134 | GRK1 | 0.24616464 |
135 | PRKCA | 0.23412624 |
136 | NME2 | 0.23402642 |
137 | PRKCD | 0.22943152 |
138 | CSF1R | 0.21744689 |
139 | MAP4K1 | 0.21454968 |
140 | CSNK1G1 | 0.20824192 |
141 | MAP3K1 | 0.20723377 |
142 | PAK3 | 0.20409616 |
143 | KIT | 0.20169238 |
144 | MAP3K6 | 0.18348747 |
145 | MAP3K5 | 0.17623216 |
146 | MTOR | 0.17339506 |
147 | MST4 | 0.16254525 |
148 | EPHB2 | 0.16136691 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.70638709 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.64494767 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97951331 |
4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.87295817 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.84366936 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.71534194 |
7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.70901279 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70784824 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66261110 |
10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.66046942 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54616106 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45746853 |
13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.38192126 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.31252237 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.29782984 |
16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.21390583 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05613257 |
18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.98377640 |
19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97672538 |
20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.89333056 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85339498 |
22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82691267 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80826029 |
24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80584881 |
25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80479393 |
26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80091346 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77045965 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73305844 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70570179 |
30 | Bile secretion_Homo sapiens_hsa04976 | 1.63993643 |
31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60189221 |
32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59058147 |
33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57329740 |
34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52123732 |
35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50783436 |
36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46967924 |
37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43432376 |
38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38543677 |
39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38411472 |
40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.33998245 |
41 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.32822285 |
42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32255517 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31943608 |
44 | Allograft rejection_Homo sapiens_hsa05330 | 1.26528166 |
45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21739088 |
46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20230978 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19291781 |
48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18463438 |
49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16827880 |
50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.16283071 |
51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15766809 |
52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14882464 |
53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14436964 |
54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12370092 |
55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12360156 |
56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10740736 |
57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.07356159 |
58 | Asthma_Homo sapiens_hsa05310 | 1.04286551 |
59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00021469 |
60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99535847 |
61 | ABC transporters_Homo sapiens_hsa02010 | 0.99136629 |
62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97320611 |
63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97181173 |
64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95788457 |
65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.91673078 |
66 | Lysine degradation_Homo sapiens_hsa00310 | 0.91569260 |
67 | Pertussis_Homo sapiens_hsa05133 | 0.90208895 |
68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89744539 |
69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87620119 |
70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84289059 |
71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80336230 |
72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78553134 |
73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73839744 |
74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72436341 |
75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69341302 |
76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65862720 |
77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64844200 |
78 | Tuberculosis_Homo sapiens_hsa05152 | 0.63031794 |
79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58370976 |
80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56618403 |
81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55813873 |
82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54461398 |
83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53065433 |
84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52717617 |
85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51782375 |
86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50689945 |
87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42486376 |
88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39340586 |
89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38879880 |
90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35437854 |
91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32023537 |
92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31881543 |
93 | Phagosome_Homo sapiens_hsa04145 | 0.29438424 |
94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28971123 |
95 | Influenza A_Homo sapiens_hsa05164 | 0.28438094 |
96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28017984 |
97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26354347 |
98 | Mineral absorption_Homo sapiens_hsa04978 | 0.23897293 |
99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21861450 |
100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19722032 |
101 | Insulin resistance_Homo sapiens_hsa04931 | 0.17505493 |
102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15144362 |
103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.15117447 |
104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14519142 |
105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14202920 |
106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12376856 |
107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11303257 |
108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09509161 |
109 | Prion diseases_Homo sapiens_hsa05020 | 0.07835942 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06368391 |
111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.06218258 |
112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06077295 |
113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05259317 |
114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.04638941 |
115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.00283711 |
116 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1926147 |
117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1751949 |
118 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1554813 |
119 | Hepatitis C_Homo sapiens_hsa05160 | -0.1247516 |
120 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.1104868 |
121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0932705 |
122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0813740 |
123 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0755255 |
124 | Lysosome_Homo sapiens_hsa04142 | -0.0346944 |
125 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0267640 |
126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0121103 |
127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0113088 |
128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0048311 |